Filing Flows › Conmed (CNMD) › Q2 2026
Conmed (CNMD) Q2 2026 earnings results (second quarter 2026)
10-Q filed Jul 29, 2026
Conmed (CNMD) reported revenue of $343M for the second quarter 2026 (Q2 2026), +0.3% from a year earlier. Operating margin was 10.6%, net earnings $23.1M (6.7% of revenue).
Conmed, Q2 2026: revenue $343M (+0.3% year over year), operating margin 10.6%, net earnings $23.1M, operating cash flow $37.1M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $343M | — | +0.3% |
| Gross profit | $197M | — | +5% |
| Operating profit | $36.4M | — | -5% |
| Net earnings | $23.1M | — | +8% |
| Operating cash flow | $37.1M | — | +27% |
| Free cash flow | $34.2M | — | +46% |
What changed
Revenue was $343.5M in Q2 2026, roughly flat year over year. General Surgery was the largest line at 56% of revenue. Orthopedic Surgery added $11.6M year over year (up 8%), 1013% of the total change. General Surgery declined 5%.
Gross margin was 57.5%, up 2.5 points from Q2 2025. Operating profit was $36.4M, a 10.6% margin (down 0.5 points year over year). Operating profit fell $1.8M even though revenue rose $1.1M versus Q2 2025, so costs grew faster than sales. Operating expenses grew 7% against flat revenue. Net earnings were $23.1M, up 8% year over year. The effective tax rate was 26.4%.
Operating cash flow was $37.1M (up 27% year over year), 161% of net earnings. Non-cash charges added back $12.8M of depreciation and amortization and $5.2M of share-based compensation. Working capital and other items used $4.0M. Capital expenditures of $2.9M left free cash flow of $34.2M.
Questions
What was Conmed's revenue in the second quarter 2026?
Conmed (CNMD) reported revenue of $343M for the second quarter 2026 (Q2 2026), +0.3% from a year earlier.
Was Conmed profitable in the second quarter 2026?
Operating profit was $36.4M (10.6% of revenue) and net earnings $23.1M.
Source: Conmed 10-Q on SEC EDGAR.